Suppression of pro-inflammatory IL-1 family members and IL-6 has been shown to have a therapeutic effect in many inflammatory diseases, including viral infections, and has been explored as a potential therapeutic avenue in COVID-19 [44]. This evidence concerns the gene IL1A and COVID-19.